切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2023, Vol. 16 ›› Issue (03) : 324 -328. doi: 10.3877/cma.j.issn.1674-6902.2023.03.005

论著

肺癌患者上肢PICC相关性静脉血栓危险因素分析
黄芳芳, 陈雅玫, 邓牡红, 石新华, 尚少梅()   
  1. 100191 北京,北京大学第三医院肿瘤化疗与放射病科
    100853 北京,解放军总医院第一医学中心肿瘤内科
    100191 北京,北京大学护理学院
  • 收稿日期:2023-02-07 出版日期:2023-06-25
  • 通信作者: 尚少梅

Risk factors analysis and prediction model of PICC-associated venous thrombosis in lung cancer patients

Fangfang Huang, Yamei Chen, Muhong Deng, Xinhua Shi, Shaomei Shang()   

  1. School of Nursing, Peking University, Beijing 100191; Department of Tumor Chemotherapy and Radiology, Peking University Third Hospital, Beijing 100191, China
    Department of Tumor Chemotherapy and Radiology, Peking University Third Hospital, Beijing 100191, China
    Department of Medical Oncology, The First Medical Center of PLA General Hospital, Beijing 100853, China
    School of Nursing, Peking University, Beijing 100191
  • Received:2023-02-07 Published:2023-06-25
  • Corresponding author: Shaomei Shang
引用本文:

黄芳芳, 陈雅玫, 邓牡红, 石新华, 尚少梅. 肺癌患者上肢PICC相关性静脉血栓危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 324-328.

Fangfang Huang, Yamei Chen, Muhong Deng, Xinhua Shi, Shaomei Shang. Risk factors analysis and prediction model of PICC-associated venous thrombosis in lung cancer patients[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(03): 324-328.

目的

分析肺癌患者发生上肢PICC相关性静脉血栓( PICC-catheter related thrombosis, PICC-CRT)危险因素,构建风险预测模型。

方法

选取2019年5月至2022年5月北京市两家三级甲等医院肿瘤内科行PICC静脉化疗肺癌患者453例为对象,根据是否发生PICC相关性静脉血栓分为血栓组48例,非血栓组405例。收集两组临床资料,进行单因素分析筛选血栓危险因素,建立预测模型列线图,采用Bootstrap法进行模型内部验证,ROC曲线评价预测模型区分度,校准曲线评价模型校准度。

结果

Logistic回归分析显示癌症分期、性别、置管前VTE风险评估、置管前活动能力评估、脑梗史、癌症转移史、D-二聚体水平是肺癌患者发生PICC相关性静脉血栓危险因素。ROC曲线分析显示曲线下面积为0.823〔95%CI(0.767,0.879)〕,最佳截断值为0.087,灵敏度为0.792,特异度为0.699,模型具有较好的区分能力和校准能力。

结论

癌症晚期(Ⅲ~Ⅳ期)、性别男、VTE评估风险偏高、活动能力评估偏低、脑梗史、癌症转移史、D-二聚体水平偏高是肺癌患者PICC相关性静脉血栓危险因素,列线图模型具有较好的区分能力和校准能力。

Objective

To analyze the risk factors of PICC catheter-associated venous thrombosis in the upper limb of lung cancer patients after PICC catheterization, and to construct a preliminary risk prediction model presented in a visual graph.

Methods

A total of 453 patients with lung cancer who received PICC intravenous chemotherapy in the Department of Oncology of two third-class A hospitals in Beijing were selected from May 2019 to May 2022. According to whether the patients had PICC-associated venous thrombosis in half a year, they were divided into thrombe group(48 cases) and non-thrombe group(405 cases). The clinical data of the two groups of patients were collected, and R. 4.2.0 software was used for univariate analysis to screen the risk factors of thrombosis. Variables with P<0.05 were included in multivariate Logistic regression analysis to determine the independent risk factors of thrombosis. A line diagram of the prediction model was established, and the Bootstrap method was used to verify the model internally. The ROC curve was used to evaluate the differentiation of the prediction model, and the calibration curve was used to evaluate the calibration degree of the model.

Results

The independent risk factors of PICC-associated venous thrombosis in patients with lung cancer were determined by Logistic regression analysis, including cancer stage, gender, pre-catheterization VTE risk assessment, pre-catheterization mobility assessment, history of cerebral infarction, history of cancer metastasis, and D-dimer level. The above risk factors were constructed by R software. The ROC curve analysis results showed that the area under the curve was 0.823 (95%CI: 0.767, 0.879), the optimal cut-off value was 0.087, the sensitivity was 0.792, and the specificity was 0.699. The model had good distinguishing ability and calibration ability.

Conclusion

Advanced cancer, male, high risk of VTE assessment, low mobility assessment, history of cerebral infarction, history of cancer metastasis, and high D-dimer level are independent risk factors for PICC-associated venous thrombosis in lung cancer patients. The line graph model built based on the above risk factors has a good ability to distinguish and calibrate.

表1 肺癌患者发生PICC-CRT危险因素单因素分析[n(%)]
临床资料   非血栓者(n=405) 血栓者(n=48) P
肺癌类型 大细胞肺癌 5(1.2) 1(2.1) 0.390
  鳞癌 108(26.7) 16(33.3)  
  腺癌 173(42.7) 16(33.3)  
  小细胞肺癌 104(25.7) 15(31.2)  
  其他 15(3.7) 0(0.0)  
置管前肺癌分期 80(19.8) 2(4.2) 0.011
  109(26.9) 9(18.8)  
  110(27.2) 19(39.6)  
  106(26.2) 18(37.5)  
性别 292(72.1) 43(89.6) 0.015
  113(27.9) 5(10.4)  
置管前VTE评分 3.19±1.18 4.06±1.97 0.000
置管前营养风险评分 1.72±1.08 2.29±1.18 0.050
置管前日常活动能力评分 87.05±8.64 82.71±9.73 0.000
脑梗史 363(89.6) 37(77.1) 0.020
  42(10.4) 11(22.9)  
癌症转移史 214(52.8) 13(27.1) 0.000
  191(47.2) 35(72.9)  
置管后放疗史 290(71.6) 40(83.3) 0.120
  115(28.4) 8(16.7)  
置管前D-二聚体(mg/L) 0.32±0.20 0.41±0.28 0.005
置管前纤维蛋白水平(g/L) 5.88±30.23 4.25±1.16 0.708
置管前凝血原酶时间(s) 11.81±1.45 11.82±0.95 0.990
置管前血小板(×109/L) 248.46±96.75 256.88±102.70 0.572
置管静脉 左上肢静脉 170(37.53) 18(3.15) 0.339
  右上肢静脉 235(51.88) 30(6.62)  
  置入长度(cm) 43.92±3.90 45.00±3.44 0.068
  臂围(cm) 26.53±2.59 27.02±2.10 0.206
尖端位置 T6 33(8.1) 2(4.2) 0.717
  T7 252(62.2) 31(64.6)  
  T8 103(25.4) 14(29.2)  
  T9 9(2.2) 1(2.1)  
  其他 8(2.0) 0(0.0)  
置管是否疑难 348(85.9) 38(79.2) 0.302
  57(14.1) 10(20.8)  
置管后靶向治疗史 320(79.0) 40(83.3) 0.609
  85(21.0) 8(16.7)  
置管后免疫治疗史记 319(78.8) 43(89.6) 0.115
  86(21.2) 5(10.4)  
体质指数(kg/m2)   23.96±3.47 24.63±3.25 0.209
表2 肺癌患者发生PICC-CRT危险因素多因素Logistic回归分析
图1 肺癌患者发生PICC-CRT危险因素的风险预测列线图
图2 列线图预测肺癌患者发生PICC-CRT的ROC曲线
图3 列线图预测肺癌患者发生PICC-CRT的校准曲线
1
王洪武,金发光. 晚期非小细胞肺癌多域整合治疗策略[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(4): 457-461.
2
Rogers C, Barod R, Schwartz S, et al. Endovascular Extraction of Caval Tumor Thrombus to Facilitate Minimally Invasive Cytoreductive Nephrectomy for Metastatic Kidney Cancer[J]. Eur Urol, 2015, 68(1): 167-168.
3
Hashimoto H, Usui G, Tsugeno Y, et al. Cerebral thromboembolism after lobectomy for lung cancer: Pathological diagnosis and mechanism of thrombus formation[J]. Cancers (Basel), 2019, 11(4): 488.
4
Periard D, Monney P, Waeber G, et al. Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy[J]. J Thromb Haemost, 2010, 6(8): 1281-1288.
5
Kang JR, Long LH, Yan SW, et al. Peripherally inserted central catheter-related vein thrombosis in patients with lung cancer[J]. Clin Appl Thromb Hemost, 2017, 23(2): 181-186.
6
Zhou L, Wang M, Aping LI. Analysis of risk factors of peripherally inserted central catheter induced catheter-related infection in patients with leukemia[J]. Iranian J Public Health, 2017, 46(4): 485-490.
7
闻 曲,成 芳,鲍爱琴. PICC临床应用及安全管理[M]. 北京:人民军医出版社,2012: 75-89.
8
Sharp R, Cummings M, Fielder A, et al. The catheter to vein ratio and rates ofsymptomatic venous thromboembolism in patients with a peripherally inserted central catheter(PICC):a prospective cohort study[J]. Int J Nurs Stud, 2015, 52(3): 677-685.
9
Wojnar DG, Beaman ML. Peripherally inserted central catheter:compliance with evidence-based indications for insertion in an inpatient setting[J]. J Infus Nurs Off Publ Infus Nurses Soc, 2013, 36(4): 291.
10
Parienti JJ, Mongardon N, Megarbane B, et al. Intravascular complications of central venous catheterization by insertion site[J]. N Engl J Med, 2015, 373(13): 1220-1229.
11
Menéndez JJ, VerdúC, Calderón B, et al. Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children[J]. J Thromb Haemost, 2016, 14(11): 2158-2168.
12
胡佳丽,项丽婷,戚红萍,等. 肿瘤化疗患者PICC相关性上肢静脉血栓形成时间及其影响因素分析[J]. 中国现代医学杂志2021, 31(6): 51-57.
13
国际血管联盟中国分会和中国老年医学学会周围血管疾病管理分会. 输液导管相关静脉血栓形成防治中国专家共识(2020版)[J]. 中国实用外科志2020, 40(4): 377-382.
14
罗 蕾,王国蓉,郭 琴,等. 肿瘤患者PICC相关上肢无症状静脉血栓的临床调查研究[J]. 中国护理管理2021, 21(1): 25-30.
15
Al-Samkari H, Leiva O, Dagogo-Jack I, et al. Impact of ALK rearrangement on venous and arterial thrombotic risk in NSCLC[J]. J Thorac Oncol, 2020, 15(9): 1497-1506.
16
王秋桐,吴 爽. 非小细胞肺癌患者凝血功能指标与肿瘤标志物的相关性及其对患者合并静脉血栓栓塞症、远端转移的诊断价值研究[J]. 实用心脑肺血管病杂志2022, 30(10): 40-46.
17
Chew HK, Davies AM, Wun T, et al. The incidence of venous thromboembolism among patients with primary lung cancer[J]. J Thromb Haemost, 2008, 6(4): 601-608.
18
Blom JW, Doggen CJ, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis[J]. JAMA, 2005, 293(6): 715-722.
19
Mahajan A, Brunson A, White R, et al. The Epidemiology of cancer-associated venous thromboembolism: an update[J]. Semin Thromb Hemost, 2019, 45(4): 321-325.
20
Galanaud JP, Sevestre MA, Pernod G, et al. Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study[J]. J Thromb Haemost, 2017, 15(5): 907-916.
21
Chopra V, Ratz D, Kuhn L, et al. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors[J]. J Thromb Haemost, 2014, 12(6): 847854.
22
罗小云,张福先. Caprini风险评估模型在综合医院住院患者中的应用[J]. 中华医学杂志2017(24): 80-93.
23
陈 林,余春华,李俊英. 肺癌患者PICC相关静脉血栓的回顾性分析[J]. 中国肺癌杂志2015, 18(9): 549-553.
24
范华颖,方 怡. 影响肺癌化疗患者PICC导管相关性静脉血栓的危险因素分析[J]. 临床误诊误治2019, 32(9): 54-58.
25
Nañez-Terreros H, Jaime-Perez JC, Muñoz-Espinoza LE, et al. D-dimer from central and peripheral blood samples in asymptomatic central venous catheter-related thrombosis in patients with cancer[J]. Phlebol, 34(1): 52-57.
26
叶 彬,秦 超,梁志坚,等. 结直肠癌合并脑梗死患者的临床特点[J]. 中华老年心脑血管病杂志2016, 18(3): 278-282.
27
刘亚媛,梁志坚,秦 超,等. 鼻咽癌合并脑梗死十例临床分析[J]. 中华耳鼻咽喉头颈外科杂志2015, 50(5): 411-414.
28
谢兴锐,秦 超,陈 莉,等. 肺癌相关脑梗死发病机制的临床研究[J]. 中华内科杂志2017, 56(2): 99-103.
[1] 刘欢颜, 华扬, 贾凌云, 赵新宇, 刘蓓蓓. 颈内动脉闭塞病变管腔结构和血流动力学特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 809-815.
[2] 马艳波, 华扬, 刘桂梅, 孟秀峰, 崔立平. 中青年人颈动脉粥样硬化病变的相关危险因素分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 822-826.
[3] 闫文, 谢兴文, 顾玉彪, 雷宁波, 马成, 于文霞, 高亚雄, 张磊. 微小RNA与全膝关节置换术后深静脉血栓的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 842-846.
[4] 陈旭渊, 罗仕云, 李文忠, 李毅. 腺源性肛瘘经手术治疗后创面愈合困难的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 82-85.
[5] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[6] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[7] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[8] 毛永欢, 仝瀚文, 缪骥, 王行舟, 沈晓菲, 喻春钊. 造口旁疝危险因素预测模型构建[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 682-687.
[9] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[10] 陆猛桂, 黄斌, 李秋林, 何媛梅. 蜂蛰伤患者发生多器官功能障碍综合征的危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1010-1015.
[11] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[12] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[13] 孟科, 李燕, 闫婧爽, 闫斌. 胶囊内镜胃通过时间的影响因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 671-675.
[14] 杨艳丽, 陈昱, 赵若辰, 杜伟, 马海娟, 许珂, 张莉芸. 系统性红斑狼疮合并血流感染的危险因素及细菌学分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 694-699.
[15] 孙培培, 张二明, 时延伟, 赵春燕, 宋萍萍, 张硕, 张克, 周玉娇, 赵璨, 闫维, 吴蓉菊, 宋丽萍, 郭伟安, 马石头, 安欣华, 包曹歆, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病患病情况及相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 711-719.
阅读次数
全文


摘要